These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31238057)

  • 1. An unusual cause of cholangiopathy.
    Aslam SP; Cacciottolo TM; Bowden D; Griffiths WJH; Godfrey EM
    Gastrointest Endosc; 2019 Nov; 90(5):850-851. PubMed ID: 31238057
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous ketamine and progressive cholangiopathy in COVID-19 patients.
    ;
    J Hepatol; 2021 May; 74(5):1243-1244. PubMed ID: 33617925
    [No Abstract]   [Full Text] [Related]  

  • 3. Consider ketamine misuse in patients with urinary symptoms.
    Cottrell AM; Gillatt D
    Practitioner; 2008 Oct; 252(1711):5. PubMed ID: 18972794
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduced functional bladder capacity associated with ketamine use.
    Ramos SP; Zambonato TK; Graziottin TM
    Braz J Psychiatry; 2019; 41(3):270-271. PubMed ID: 31189007
    [No Abstract]   [Full Text] [Related]  

  • 5. Ketamine analogues multiplying in Hong Kong.
    Li C; Lai CK; Tang MHY; Chan CCK; Chong YK; Mak TWL
    Hong Kong Med J; 2019 Apr; 25(2):169. PubMed ID: 30971512
    [No Abstract]   [Full Text] [Related]  

  • 6. Recreational ketamine-induced cholangiopathy and ulcerative cystitis.
    Vu DM; Freyre K; Opsha O; Opsha Y
    Am J Emerg Med; 2021 Jul; 45():682.e7-682.e9. PubMed ID: 33358897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance cholangiogram patterns and clinical profiles of ketamine-related cholangiopathy in drug users.
    Seto WK; Mak SK; Chiu K; Vardhanabhuti V; Wong HF; Leong HT; Lee PSF; Ho YC; Lee CK; Cheung KS; Yuen MF; Leung WK
    J Hepatol; 2018 Jul; 69(1):121-128. PubMed ID: 29551711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine abuse, biliary tract disease, and secondary sclerosing cholangitis.
    Turkish A; Luo JJ; Lefkowitch JH
    Hepatology; 2013 Aug; 58(2):825-7. PubMed ID: 23695896
    [No Abstract]   [Full Text] [Related]  

  • 9. Direct visualization of IgG4-related cholangiopathy.
    Yu CY; Patel S; Buxbaum J
    Gastrointest Endosc; 2018 Feb; 87(2):614-615. PubMed ID: 28842167
    [No Abstract]   [Full Text] [Related]  

  • 10. Ureteric intestinal metaplasia in association with chronic recreational ketamine abuse.
    Hopcroft SA; Cottrell AM; Mason K; Abrams P; Oxley JD
    J Clin Pathol; 2011 Jun; 64(6):551-2. PubMed ID: 21345876
    [No Abstract]   [Full Text] [Related]  

  • 11. A REVIEW OF KETAMINE ABUSE AND DIVERSION.
    Sassano-Higgins S; Baron D; Juarez G; Esmaili N; Gold M
    Depress Anxiety; 2016 Aug; 33(8):718-27. PubMed ID: 27328618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine-induced biliary dilatation: from Hong Kong to New York.
    Gutkin E; Hussain SA; Kim SH
    J Addict Med; 2012 Mar; 6(1):89-91. PubMed ID: 22124288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine for the treatment of depression: what about the addictive potential?
    Hillemacher T; Bleich S; Demling J; Kornhuber J
    Aust N Z J Psychiatry; 2007 Sep; 41(9):772-3. PubMed ID: 17896416
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dissociative anesthesia, with special reference to psychological disorders caused by ketamine].
    Poletto TA
    Ann Osp Maria Vittoria Torino; 1974; 17(1-6):122-30. PubMed ID: 4466408
    [No Abstract]   [Full Text] [Related]  

  • 15. Ketamine-related cholangiopathy: a retrospective study on clinical and imaging findings.
    Yu WL; Cho CC; Lung PF; Hung EH; Hui JW; Chau HH; Chan AW; Ahuja AT
    Abdom Imaging; 2014 Dec; 39(6):1241-6. PubMed ID: 24934474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver injury is common among chronic abusers of ketamine.
    Wong GL; Tam YH; Ng CF; Chan AW; Choi PC; Chu WC; Lai PB; Chan HL; Wong VW
    Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1759-62.e1. PubMed ID: 24534547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of magnetic resonance cholangiopancreatography/magnetic resonance splenoportovenography and endoscopic ultrasound in the diagnosis of portal cavernoma cholangiopathy.
    Rai GP; Nijhawan S; Madhu MP; Sharma SS; Pokharna R
    Indian J Gastroenterol; 2015 Nov; 34(6):442-7. PubMed ID: 26743101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in research of ketamine addiction mechanism].
    Liu WL; Bian SZ; Gu ZL; Jiang XG; Qin ZH
    Fa Yi Xue Za Zhi; 2009 Jun; 25(3):200-3, 207. PubMed ID: 19697780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of ketamine dependence].
    Błachut M; Sołowiów K; Janus A; Ruman J; Cekus A; Matysiakiewicz J; Hese RT
    Psychiatr Pol; 2009; 43(5):593-9. PubMed ID: 20214100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine treatment of long-term ketamine abuse-related lower urinary tract symptoms: a case report.
    Chao JY; Shai HA
    Gen Hosp Psychiatry; 2010; 32(6):647.e5-6. PubMed ID: 21112463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.